SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
35322025 looks good with lag3 and Il-33 potential. Starting 1 Muscle maintenanceBiotechwantabe-3/12/2024
3531Thanks for that summary. 3 shots for new approvals and easier reimbursement comiA.J. Mullen-3/8/2024
3530Upcoming dates: Odronextamab March 31. FDA Decision Eylea April 1. Jcode DuBiotechwantabe13/8/2024
35292024 guesstimate Dupi 11.588b +30% +3.5b. (COPD +?) Eylea 9.38b -5% -.5b. (Biotechwantabe-2/5/2024
3528Sanofi q4 feb1/24Biotechwantabe12/1/2024
3527Conference call is tomorrow. Have they already announced Q4 earnings?A.J. Mullen-2/1/2024
3526Dupi q4 €2.99B 31.3% growth.Biotechwantabe-2/1/2024
3525No reason for Len or George to retire, George has the best drugs available AlzhBiotechwantabe-1/11/2024
3524Sanofi report dupi, not REGN. So, 1.46 B (flat) sale is in line with expected, sMiljenko Zuanic-1/11/2024
3523Eylea 1.46b q4 2023 -2.6% vs 1.5b for q4 2022 -3% Still bleeding slowly.Biotechwantabe-1/8/2024
3522If they can spot the bleeding of eylea with the HD. Then COPD for dupy should bBiotechwantabe-1/6/2024
3521Thoughts on the recent climb? The initial uptick from the Eylea biosimilar litiFelix B-1/4/2024
3520Looks like aln-app EOAD is moving forward investor.regeneron.com And next TAUBiotechwantabe-10/5/2023
3519ATH - All time high of the stock price. Your right it doesn’t mean much. EveBiotechwantabe-8/23/2023
3518Covid clinical deal with BARDABiotechwantabe-8/22/2023
3517I have to admit, ATH doesn't mean anything to me. I did find this informatiA.J. Mullen-8/22/2023
3516Eylea 8mg pricing. Nice to see ATH again.Biotechwantabe-8/22/2023
3515I had missed this, a higher dose for Eylea, finance.yahoo.com. This was more imA.J. Mullen18/21/2023
3514 The FDA approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Veopoz (pA.J. Mullen18/21/2023
3513No, but congratulations to you and anyone else here who does..A.J. Mullen-8/9/2023
3512ir.decibeltx.com Anyone else have Decibel shares?Biotechwantabe-8/9/2023
3511Q1 Dupi +40%. Q2 34%. On track for 10b € and still growing.Biotechwantabe-7/28/2023
3510Q2 Roche impact Q1 cov2 Roche shipment to Japan +568m. Not expected. Q2 550m Biotechwantabe-7/27/2023
3509BBB-TARGETED GAA DELIVERED AS GENE THERAPY TREATS CNS AND MUSCLE IN POMPE DISEASBiotechwantabe-7/17/2023
3508No impact on future sales.DewDiligence_on_SI-5/18/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):